Related references
Note: Only part of the references are listed.Phase I Study of the Angiogenesis Inhibitor BIBF 1120 in Patients with Advanced Solid Tumors
Klaus Mross et al.
CLINICAL CANCER RESEARCH (2010)
Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: Current status and perspectives
Michele Lamuraglia et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy
I. M. E. Desar et al.
CANCER TREATMENT REVIEWS (2009)
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
Robert B. Campbell et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with cisplatin
Sebastian Strieth et al.
CLINICAL CANCER RESEARCH (2008)
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes
Sebastian Strieth et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Phase I clinical study of AZD2171, an oral vascular endothelial growth factor signaling inhibitor, in patients with advanced solid tumors
Joachim Drevs et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents
J. P. B. O'Connor et al.
BRITISH JOURNAL OF CANCER (2007)
Functional imaging of colorectal cancer angiogenesis
Vicky Goh et al.
LANCET ONCOLOGY (2007)
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
Nola Hylton
JOURNAL OF CLINICAL ONCOLOGY (2006)
Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging
TE Yankeelov et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2006)
Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer
SB Wedam et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance Imaging
ME Eichhorn et al.
CANCER BIOLOGY & THERAPY (2006)
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths
M Rohrer et al.
INVESTIGATIVE RADIOLOGY (2005)
Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: Results from a phase I study
G Liu et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours
K Mross et al.
EUROPEAN JOURNAL OF CANCER (2005)
Soluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trials
J Drevs et al.
ANNALS OF ONCOLOGY (2005)
Phase II study of the Flk-1 tyrosine kinase inhibitor SU5416 in advanced melanoma
AC Peterson et al.
CLINICAL CANCER RESEARCH (2004)
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126
JL Evelhoch et al.
CLINICAL CANCER RESEARCH (2004)
Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature
S Streith et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
On the transient phase of balanced SSFP sequences
K Scheffler
MAGNETIC RESONANCE IN MEDICINE (2003)
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a humanized SCID mouse model
R Kunstfeld et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
